Get started
222

SENZAGEN AB

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

26S chart


Full chart

Key stats


Market capitalization
‪18.54 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−1.98 M‬ EUR
Revenue (FY)
‪4.46 M‬ EUR
Shares float
‪22.45 M‬
Beta (1Y)
0.24

About SENZAGEN AB


Sector
Health Technology
Industry
Biotechnology
CEO
Peter Nählstedt
Website
senzagen.com
Headquarters
Lund
Founded
2010
ISIN
SE0010219626
FIGI
BBG00HVT8T57
SenzaGen AB engages in the development of in vitro test methods for prediction of chemical and protein sensitizers. It offers services for assessment of sensitizers for industry and regulatory purposes, using its proprietary technology called GARD (Genomic Allergen Rapid Detection). It serves clients in cosmetic, chemical, pharmaceutical, and food industries. The company was founded by Malin Marie Lindstedt and Carl Arne Krister Borrebaeck on August 18, 2010 and is headquartered in Lund, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

26S news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BER exchange SENZAGEN AB stocks are traded under the ticker 26S.
We've gathered analysts' opinions on SENZAGEN AB future price: according to them, 26S price has a max estimate of 1.49 EUR and a min estimate of 1.49 EUR. Watch 26S chart and read a more detailed SENZAGEN AB stock forecast: see what analysts think of SENZAGEN AB and suggest that you do with its stocks.
26S reached its all-time high on Aug 14, 2018 with the price of 6.693 EUR, and its all-time low was 0.489 EUR and was reached on Feb 8, 2024. View more price dynamics on 26S chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track SENZAGEN AB financials in yearly and quarterly reports right on TradingView.
26S net income for the last quarter is ‪−207.19 K‬ EUR, while the quarter before that showed ‪−679.14 K‬ EUR of net income which accounts for 69.49% change. Track more SENZAGEN AB financial stats to get the full picture.
No, 26S doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 34.00 employees. See our rating of the largest employees — is SENZAGEN AB on this list?
Like other stocks, 26S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SENZAGEN AB stock right from TradingView charts — choose your broker and connect to your account.